Antibiotic prophylaxis in total hip replacement

Area of Science:

• Orthopedic Surgery
• Infectious Disease Prevention
• Clinical Trials

Background:

• Surgical site infections (SSIs) are a significant complication following total hip replacement (THR).
• Prophylactic antibiotic use is standard practice to minimize infection risk.
• Comparing short-course versus extended-course antibiotic regimens is crucial for optimizing treatment strategies.

Observation:

• A controlled prospective trial involving 297 patients undergoing 310 total hip replacements was conducted.
• Patients received either cephaloridine (short-course) or flucloxacillin (extended-course) prophylaxis.
• Follow-up ranged from one to two and a half years, with deep infection rates meticulously recorded.

Findings:

• The overall deep infection rate was 1.3% (4 out of 310 procedures).
• Cephaloridine (3 doses) demonstrated equivalent efficacy to flucloxacillin (14 days) in preventing deep infections.
• Prophylactic systemic antibiotics lowered infection rates to levels comparable to ultra-clean-air environments.

Implications:

• Short-course cephaloridine offers a potentially more convenient and cost-effective prophylactic strategy for total hip replacement.
• These findings support the use of systemic antibiotics in conventional operating theaters to achieve infection rates similar to specialized environments.
• Further research could explore optimal antibiotic selection and duration for various orthopedic procedures.